Compare SGRY & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGRY | ENOV |
|---|---|---|
| Founded | 2004 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2015 | 2008 |
| Metric | SGRY | ENOV |
|---|---|---|
| Price | $13.09 | $25.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 8 |
| Target Price | $22.25 | ★ $47.38 |
| AVG Volume (30 Days) | ★ 1.1M | 670.4K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.14 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,145,438,000.00 | N/A |
| Revenue This Year | $5.09 | $6.36 |
| Revenue Next Year | $5.67 | $5.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.41 | $21.00 |
| 52 Week High | $24.10 | $36.82 |
| Indicator | SGRY | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 61.35 |
| Support Level | $11.51 | $21.37 |
| Resistance Level | $16.15 | $26.41 |
| Average True Range (ATR) | 0.44 | 1.04 |
| MACD | 0.23 | 0.31 |
| Stochastic Oscillator | 86.81 | 87.56 |
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities, which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earn revenues from contracts with patients in which the performance obligations are to provide health care services.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.